UPDATED Apr 16, 2024
Potentially undervalued companies with a strong past performance and robust balance sheet.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NOVN | CHF85.00 | -1.3% | -3.7% | CHF186.1b | CHF97.60 | PE23.8x | E9.5% | 3.9% | Pharmaceuticals & Biotech | ||
ROG | CHF221.50 | -1.3% | -19.5% | CHF178.3b | CHF281.61 | PE15.4x | E8.1% | 4.3% | Pharmaceuticals & Biotech | ||
CFR | CHF127.95 | -4.1% | -14.4% | CHF75.2b | CHF146.25 | PE19.5x | E7.9% | 2.7% | Consumer Durables | ||
ALC | CHF72.94 | -2.7% | 14.9% | CHF36.0b | CHF85.20 | PE40.5x | E10.5% | 0.3% | Healthcare | ||
TECN | CHF337.20 | -4.6% | -15.0% | CHF4.3b | CHF395.57 | PE32.7x | E9.2% | 0.9% | Pharmaceuticals & Biotech | ||
SUN | CHF114.20 | 1.1% | 48.2% | CHF3.9b | CHF123.80 | PE16.9x | E8.0% | 3.3% | Capital Goods | ||
SQN | CHF246.40 | -1.2% | 31.0% | CHF3.7b | CHF247.00 | PE16.8x | E14.3% | 1.7% | Diversified Financials | ||
MOVE | CHF115.00 | -3.5% | 3.2% | CHF2.3b | CHF142.95 | PE49.9x | E21.8% | 0.5% | Healthcare | ||
BCHN | CHF588.00 | -1.3% | 3.0% | CHF2.0b | CHF604.50 | PE25.6x | E12.8% | 2.0% | Capital Goods | ||
LEHN | CHF1,572.00 | -6.9% | -25.0% | CHF1.8b | CHF2,113.25 | PE23.7x | E9.9% | 3.3% | Tech | ||
ASCN | CHF7.83 | -5.1% | -12.0% | CHF281.2m | CHF12.17 | PE16.2x | E12.9% | 3.8% | Healthcare | ||
CICN | CHF50.40 | -3.1% | 14.0% | CHF162.7m | CHF69.63 | PE26.7x | E30.7% | 0% | Tech |